BamSEC and AlphaSense Join Forces
Learn More

Osiris Therapeutics, Inc.

Formerly NASDAQ: OSIR
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1.4
from 10-K 10 pages Osiris Therapeutics, Inc. Stock Option Award Agreement Terms and Conditions
12/34/56
EX-10.1
from 8-K 3 pages [·], 2018 [Name] [Address] Re: Indemnification and Advancement of Expenses Dear [Name]
12/34/56
EX-10.9
from 10-K 6 pages Separation and Release Agreement
12/34/56
EX-10.6
from 10-K 2 pages April 17, 2017 by Email (Yc506@yahoo.com) Linda L. Chang 141 Central Avenue Gaithersburg, MD 20877 Re: Chief Financial Officer, Osiris Therapeutics, Inc. These Are the Offered Terms and Conditions of Employment
12/34/56
EX-10.5
from 10-K 5 pages Director Agreement
12/34/56
EX-10.2
from 8-K 8 pages Employee Confidentiality, Noncompetition and Invention Agreement
12/34/56
EX-10.1
from 8-K 18 pages Employment Agreement
12/34/56
EX-10.9
from 10-K/A 30 pages Exclusive Service Agreement
12/34/56
EX-10.7
from 10-K/A 11 pages Third Amendment to Agreement of Lease
12/34/56
EX-10.1
from 8-K/A 2 pages June 23, 2016 Mr. David A. Dresner Re: Interim Chief Executive Officer and President Dear Dave: We’re Delighted to Extend This Offer of Employment for the Position of Interim Chief Executive Officer of Osiris Therapeutics, Inc. if You Accept This Offer, Your Employment Will Start Immediately. These Are the Terms and Conditions of Your Employment if You Accept This Offer
12/34/56
EX-10.1
from 8-K/A 21 pages Separation and Release Agreement
12/34/56
EX-10.9
from 10-K 28 pages Exclusive Service Agreement
12/34/56
EX-10.7
from 10-K 10 pages Third Amendment to Agreement of Lease
12/34/56
EX-10.7
from 10-K 64 pages Confidential Purchase Agreement by and Between Mesoblast International Sàrl (“Msb”) and Osiris Therapeutics, Inc. (“Oti”) Dated as of October 10, 2013
12/34/56
EX-10.1
from 8-K 5 pages Employment Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 17 pages Recitals
12/34/56
EX-10.1
from 10-Q 5 pages Osiris Therapeutics, Inc. Common Stock Purchase Warrant
12/34/56
EX-10.1
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 19 pages Osiris Therapeutics, Inc. Amended and Restated 2006 Omnibus Plan
12/34/56
EX-10.1
from 8-K 5 pages Employment Separation Agreement and Release
12/34/56